ArticleMolecules (Basel, Switzerland)2025
Development of 2,1,3-Benzothiadiazole-Based Room-Temperature Fluorescent Nematic Liquid Crystals.
Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Fluorescent liquid crystals (LCs) have attracted considerable interest owing to their unique combination of fluidity, anisotropy, and intrinsic emission. However, most reported fluorescent LCs exhibit high phase transition temperatures and/or smectic phases, limiting their practical applications. To address this, we designed and synthesized a series of 2,1,3-benzothiadiazole (BTD)-based fluorescent nematic liquid crystals incorporating donor (D) or acceptor (A) groups to form D-A-D or D-A-A structures. Most of the synthesized derivatives exhibited supercooled nematic phases at room temperature. They composed various functional groups, such as secondary alkylamine, branched alkyl chain, and trifluoroacetyl groups, which are rarely used in calamitic nematic LCs. Notably, dimethylamine- and carbonyl-substituted derivatives exhibited relatively high fluorescence quantum yields (Φ
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.